|
|
|
The primary activity of Dasan Medichem Co.,Ltd. is the manufacture and marketing of differentiated and value-added bulk pharmaceuticals to meet the diversified need of formulation companies.
Proprietary technology
(Micro-encapsulation for T/M(= Taste Masking))
1)Microencapsulated Acetaminophen T/M
2)Microencapsulated Ibuprofen T/M
3)Microencapsulated Clarithromycin T/M
4)Microencapsulated Roxithromycin T/M
(Enteric Coating (= E/C))
5)Pancreatin E/C pellet
(Solidification / Direct compression)
6)Simethicone powder(simethicone 70% activity)
7)Dimethicone powder(dimethicone 60% activity)
(Controlled Release)
8) Roxatidine acetate HCl coated on pellet
9) Pseudoephedrine HCl E/R pellet
10) Pseudoephedrine HCl E/R with Cetirizine pellet
11) Nifedipine S/R pellet
(E/R = Extended Release, S/R = Sustained Release)
(Trituration)
12)Glimepiride granule, DC grade (2mg/170mg Tab)
(Others)
13)Amlodipine Maleate (coated for stability protection against light and moisture)
|
회원 가입일 |
2005/08/26 (년/월/일) |
역할 구분 |
판매상 |
사업형태 |
제조업체 |
설립년도 |
1996 |
총 종업원수 |
11 - 50 |
연간매출 |
USD 2,000,001 - 5,000,000 |
|
[ 연락처 정보 ] |
회사명 |
다산메디켐 |
주소 |
서울 영등포구 문래동3가 우리벤쳐타운II 1204호 (우:150-836) 한국 |
전화번호 |
82 - 2 - 26795206 |
팩스번호 |
82 - 2 - 26795208 |
홈페이지 |
www.dspharm.com |
담당자 |
Jaeil Kim / Assist Manaer |
|
|
|
|
|
|
|
|